Reading room

Terapia April 2021 NR 4 ( 399 )

Allergology

Editor of the issue: prof. dr hab. n. med. Piotr Kuna

Contents:

Recommendations of GINA experts on the management of asthma patients during a pandemic

    Authors:
  • dr n. med. Izabela Kupryś-Lipińska
  • prof. dr hab. n. med. Piotr Kuna
Keywords: asthma, COVID-19, inhaled corticosteroids, biologi-cal therapies, vaccination against COVID-19

Prevention of asthma exacerbations in the recommendations of GINA experts

    Authors:
  • dr n. med. Izabela Kupryś-Lipińska
  • prof. dr hab. n. med. Piotr Kuna
Keywords: asthma exacerbations, maintenance and reliever therapy, biologic therapy, anticholinergic therapy

What's new in GOLD 2021

    Authors:
  • prof. nadzw. dr hab. n. med. Michał Panek
  • dr n. med. Grzegorz Kardas
  • lek. Mateusz Marynowski
  • mgr Jacek Plichta
  • prof. dr hab. n. med. Piotr Kuna
Keywords: chronic obstructive pulmonary disease [COPD], new guidelines GOLD Report, Modified British Medical Research Council [mMRC], COPD Assessment Test [CAT], the global assessment of COPD

Safety of formoterol treatment in asthma and COPD

    Authors:
  • dr n. med. Grzegorz Kardas
  • prof. dr hab. n. med. Piotr Kuna
Keywords: formoterol, asthma, chronic obstructive pulmonary disease [COPD], side effects

Treatment of patients with chronic respiratory diseases during the COVID-19 pandemic

    Authors:
  • dr n. med. Katarzyna Jarmakowska
  • prof. dr hab. n. med. Piotr Kuna
Keywords: chronic respiratory diseases, asthma, COPD, COVID-19, inhaled steroids

Factors influencing compliance to preventative measures related to the COVID-19 pandemic

    Authors:
  • mgr Dorota Szydłowska
  • prof. dr hab. n. med. Piotr Kuna
Keywords: COVID-19, compliance, physician‒patient communication, social influence

New perspective on triple therapy in asthma

    Authors:
  • lek. Mateusz Marynowski
  • prof. dr hab. n. med. Piotr Kuna
  • prof. nadzw. dr hab. n. med. Michał Panek
Keywords: triple therapy, asthma, single inhaler

Glycopyrronium in asthma

    Authors:
  • prof. dr hab. n. med. Maciej Kupczyk
  • prof. dr hab. n. med. Piotr Kuna
Keywords: asthma, anticholinergic drugs, double bronchodilatation, triple therapy, glycopyrronium bromide

Use of dupilumab in type 2 asthma

    Authors:
  • dr n. med. Marcelina Koćwin
  • prof. dr hab. n. med. Piotr Kuna
Keywords: dupilumab, asthma, Th2 inflammation, anty IL-4/IL-13 antibody

Bronchial hyperresponsiveness in clinical practice

    Authors:
  • prof. dr hab. n. med. Rafał Pawliczak
Keywords: bronchial hyperresponsiveness, asthma, treatment

The latest guidelines for the treatment of allergic rhinitis - the use of nasal glucocorticosteroids

    Authors:
  • lek. Marcelina Przemęcka
  • prof. dr hab. n. med. Piotr Kuna
Keywords: allergic rhinitis, ARIA, intranasal corticosteroids, mometasone furoate

Bacterial lysates in the therapy of respiratory diseases

    Authors:
  • mgr farm. Katarzyna Molińska
  • prof. dr hab. n. med. Paweł Majak
  • prof. dr hab. n. med. Piotr Kuna
Keywords: immunomodulation, bacterial lysates, respiratory tract infection

Treatment of severe atopic dermatitis - the latest biological treatment

    Authors:
  • dr n. med. Grzegorz Kardas
  • prof. dr hab. n. med. Piotr Kuna
Keywords: atopic dermatitis, dupilumab, biological treatment

Urticaria ‒ the use of antihistaminic drugs

    Authors:
  • lek. Marcelina Przemęcka
  • prof. dr hab. n. med. Piotr Kuna
Keywords: urticaria, H1-antihistamines, bilastine, COVID-19

Nebulization of drugs in patients with respiratory diseases during the SARS-CoV-2 pandemic. Is it really at risk, or how to understand scientific research and recommendations?

    Authors:
  • lek. Maria Mozga
  • prof. dr hab. n. med. Piotr Kuna
Keywords: nebulization, nebulizers, inhaled glucocorticosteroids, COVID-19, SARS-CoV-2

Anaphylactic shock ‒ vaccines-induced and beyond...

    Authors:
  • dr n. med. Marta Kołacińska-Flont
  • lek. Maria Mozga
  • prof. dr hab. n. med. Piotr Kuna
Keywords: anaphylaxis, anaphylactic shock, vaccines related anaphylaxis, mRNA vaccines to SARS-CoV-2, PEG, allergy to PEG, assessing eligilibity to vaccines in people with allergy to vaccine excipients

Effect of probiotics, supplements and foods activating Nrf2 on COVID-19

    Authors:
  • dr n. med. Marcelina Koćwin
  • prof. dr hab. n. med. Piotr Kuna
Keywords: Nrf2, TRPA1, TRPV1, COVID-19, diet, fermented vegetables, spices